Skip to main content

Table 2 Stratified results for different empirical prescribing. Unadjusted analysis

From: Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study

 

Monotherapy penicillin G/V (n = 335)

Combination penicillin G and gentamicin (n = 149)

Other antibiotics (n = 167)

p-value*

n (%)

n (%)

n (%)

Age, years

 Mean

72.8

70.8

70.4

0.29

 Gender, female

150 (44.8)

67 (45.0)

86 (51.5)

0.33

Comorbidities

 COPD

94 (28.1)

44 (29.5)

67 (40.1)

0.02

 Heart failure

73 (21.8)

26 (17.5)

41 (24.6)

0.30

 Diabetes mellitus I or II

50 (14.9)

13 (8.7)

22 (13.2)

0.17

Nursing home resident

27 (8.1)

22 (14.8)

21 (12.6)

0.06

Penicillin allergy

8 (2.4)

2 (1.3)

60 (35.9)

0.00

CRB-65

   

0.11

 0

57 (17.0)

23 (15.4)

30 (18.0)

 

 1

127 (37.9)

38 (25.5)

60 (35.9)

 

 2

87 (26.0)

46 (30.9)

46 (27.5)

 

 3

15 (4.5)

17 (11.4)

11 (6.6)

 

 4

2 (0.6)

2 (1.3)

2 (1.2)

 

 Missing data

47 (14.0)

23 (15.4)

18 (10.8)

 

Antibiotic use pre-hospitalization

64 (19.1)

40 (26.9)

67 (40.1)

0.00

Treatment amended within 3 days

56 (16.7)

25 (16.8)

25 (15.0)

0.87

IV treatment duration, mean (days)

3.4

4.1

4.1

0.01

Total treatment duration, mean (days)

11.4

12.3

11.3

0.04

Clinical outcomes

 30-day readmission

38 (11.6)

19 (13.4)

33 (20.8)

0.02

 Length of stay (mean)

5.1

5.8

5.0

0.20

 30-day mortality

20 (6.0)

11 (7.4)

13 (7.8)

0.70

  1. CRB-65 Confusion, respiration, blood pressure and age ≥ 65y, COPD Chronic obstructive pulmonary disease, IV intravenous
  2. *Categorical data analyzed using Pearson’s χ2-test and continuous data using ANOVA test